Sagespring Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
17,974
+2,258
+14% +$202K 0.03% 228
2026
Q1
$1.13M Buy
15,716
+198
+1% +$15.3K 0.02% 295
2025
Q4
$1.23M Buy
15,518
+679
+5% +$53.5K 0.02% 270
2025
Q3
$1.12M Buy
14,839
+104
+0.7% +$7.13K 0.02% 285
2025
Q2
$1.02M Buy
14,735
+1,994
+16% +$131K 0.02% 280
2025
Q1
$863K Buy
12,741
+5,980
+88% +$358K 0.02% 268
2024
Q4
$303K Buy
+6,761
New +$379K 0.01% 476

Other funds holding CVS

Sagespring Wealth Partners's CVS Position: Q2 2026 in Review

Sagespring Wealth Partners increased its CVS Health (CVS) stake by 14% in Q2 2026, buying an estimated $202K and bringing the position to 17,974 shares worth $1.86M. The position accounts for 0.03% of the portfolio, ranked #228.

Sagespring Wealth Partners first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Sagespring Wealth Partners held 17,974 shares of CVS Health worth $1.86M as of Q2 2026.
  • Sagespring Wealth Partners bought 2,258 CVS Health shares in Q2 2026, an estimated $202K.
  • CVS Health made up 0.03% of Sagespring Wealth Partners's portfolio in Q2 2026, its #228 holding.
  • Sagespring Wealth Partners first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.